The MFDS handles several types of drug applications, including New Drug Applications (NDA) for new chemical entities, Biologics License Applications (BLA) for biologics, Abbreviated New Drug Applications (ANDA) for generics, and Investigational New Drug (IND) applications for clinical trials. Each undergoes a detailed review for safety, efficacy, and quality.